1. Home
  2. ARDX vs NWN Comparison

ARDX vs NWN Comparison

Compare ARDX & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • NWN
  • Stock Information
  • Founded
  • ARDX 2007
  • NWN 1859
  • Country
  • ARDX United States
  • NWN United States
  • Employees
  • ARDX N/A
  • NWN N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • NWN Oil/Gas Transmission
  • Sector
  • ARDX Health Care
  • NWN Utilities
  • Exchange
  • ARDX Nasdaq
  • NWN Nasdaq
  • Market Cap
  • ARDX 1.4B
  • NWN 1.6B
  • IPO Year
  • ARDX 2014
  • NWN N/A
  • Fundamental
  • Price
  • ARDX $5.06
  • NWN $41.44
  • Analyst Decision
  • ARDX Buy
  • NWN Strong Buy
  • Analyst Count
  • ARDX 8
  • NWN 2
  • Target Price
  • ARDX $9.93
  • NWN $43.50
  • AVG Volume (30 Days)
  • ARDX 3.6M
  • NWN 187.9K
  • Earning Date
  • ARDX 02-20-2025
  • NWN 02-28-2025
  • Dividend Yield
  • ARDX N/A
  • NWN 4.73%
  • EPS Growth
  • ARDX N/A
  • NWN N/A
  • EPS
  • ARDX N/A
  • NWN 2.06
  • Revenue
  • ARDX $333,615,000.00
  • NWN $1,137,832,000.00
  • Revenue This Year
  • ARDX $169.30
  • NWN $0.04
  • Revenue Next Year
  • ARDX $14.87
  • NWN $8.35
  • P/E Ratio
  • ARDX N/A
  • NWN $20.11
  • Revenue Growth
  • ARDX 168.06
  • NWN N/A
  • 52 Week Low
  • ARDX $4.32
  • NWN $34.82
  • 52 Week High
  • ARDX $9.83
  • NWN $44.25
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 41.70
  • NWN 58.97
  • Support Level
  • ARDX $5.37
  • NWN $40.80
  • Resistance Level
  • ARDX $6.55
  • NWN $41.51
  • Average True Range (ATR)
  • ARDX 0.31
  • NWN 0.61
  • MACD
  • ARDX -0.02
  • NWN 0.12
  • Stochastic Oscillator
  • ARDX 0.67
  • NWN 91.22

About ARDX Ardelyx Inc.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

Share on Social Networks: